---
title: "Morning Trend | MEDSCI funds are on the sidelines, will it be a volume-driven surge or a defensive approach?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265675712.md"
description: "MEDSCI (2415.HK) continued to perform poorly yesterday, with the pharmaceutical sector lacking positive stimuli and a bearish sentiment prevailing. Although there was an initial attempt to rise at the beginning of the trading session, it quickly fell back. The overall phenomenon is characterized by converging trading volume and a wait-and-see attitude from major players, with industry news being bleak and the company lacking announcements to provide support, resulting in a severe lack of short-term driving force. The MACD remains in a death cross, indicating a significant weak pattern, and both RSI and the volume-price relationship are not ideal. HKD 1.47 has become a key support zone, with a clear willingness from market leaders to defend it. If it comes under pressure but receives capital replenishment, there may be a partial rebound; conversely, a weak rebound is likely to become a false signal for bullishness. During the trading session, it is essential to closely monitor policy news and capital movements. If there are no significant marginal changes, the risk of high short-term volatility will continue to exist, and investors should focus on risk management"
datetime: "2025-11-14T01:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265675712.md)
  - [en](https://longbridge.com/en/news/265675712.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265675712.md)
generator: "portal-rs"
---

# Morning Trend | MEDSCI funds are on the sidelines, will it be a volume-driven surge or a defensive approach?

MEDSCI (2415.HK) continued to perform poorly yesterday, with the pharmaceutical sector lacking positive stimuli and a bearish sentiment prevailing. Although there was an initial attempt to rise at the beginning of the trading session, it quickly fell back. The overall phenomenon shows a convergence of trading volume and a wait-and-see attitude from major players, with industry news being bleak and the company lacking announcements to provide support, resulting in a severe lack of short-term driving force. The MACD remains in a death cross, indicating a significant weak pattern, and both RSI and the volume-price relationship are not ideal. HKD 1.47 has become a key support zone, with a clear defensive willingness from market leaders. If it comes under pressure but receives capital replenishment, there may be a partial rebound; conversely, a weak rebound is likely to become a false signal for bullishness. During the trading session, it is essential to closely monitor policy news and capital movements. If there are no significant marginal changes, the risk of high short-term volatility will continue to exist, and investors should focus on risk management

### Related Stocks

- [02415.HK](https://longbridge.com/en/quote/02415.HK.md)

## Related News & Research

- [Akeso, Summit cancer drug confirms lung cancer survival benefit](https://longbridge.com/en/news/298059867.md)
- [In Focus|Faster and cheaper: why Hongkongers are heading north for medical care](https://longbridge.com/en/news/297988414.md)
- [Country Garden files HKEX next-day disclosure return, share count rises by 40,647,671 on bond conversions](https://longbridge.com/en/news/297758043.md)
- [China Nonferrous Mining completes issue of USD 300 million zero-coupon convertible bonds due 2031](https://longbridge.com/en/news/297784174.md)
- [SINO LAND Full-Year Underlying Profit Falls 6.4%; Final DPS Kept at HKD0.43](https://longbridge.com/en/news/297624387.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**